Every night, millions of Americans go to bed and drift into an evening of sleep that is anything but peaceful. They snore and gasp for air throughout the night, causing chronic sleepiness and ...
Healio Pulmonology has compiled the top news on obstructive sleep apnea posted in 2025.Readers were most interested in ...
In a new study, researchers investigated inflammatory cytokines that are associated with both obstructive sleep apnea (OSA) and autoimmune diseases. They found that cytokine levels are abnormal in ...
Share on Pinterest A clinical trial shows that Zepbound and Mounjaro reduced obstructive sleep apnea symptoms in people with obesity. NurPhoto/Getty Images Around 70% of people who have obstructive ...
Share on Pinterest Obstructive sleep apnea symptoms may worsen on weekends, a trend researchers are calling “social apnea.” Getty Images A large study found that moderate to severe obstructive sleep ...
The pill showed "significant" reductions in airway obstruction after 26 weeks. The first oral pill for obstructive sleep apnea (OSA) could be around the corner after pharmaceutical company Apnimed Inc ...
If you or a loved one has sleep apnea, you may be considering different treatment options. A new treatment you may hear about is Zepbound (tirzepatide). In December 2024, Zepbound became the first FDA ...
The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA). On Dec. 20, the FDA announced that the agency has approved Eli Lilly’s Zepbound ...
Parkinson's disease affects more than 1.1 million people in the U.S. Early treatment of obstructive sleep apnea -- a condition that causes breathing to briefly pause -- may decrease the risk of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback